Agilent Technologies, Inc. (NYSE: A) is a large market cap stock with a market cap of 15384.21. It is in the Medical Laboratories & Research industry and sector Healthcare, with a current P/E of 32.48, a forward P/E of 21.61 and EPS of 1.46. At a stock price of 47.32 (0.13%) it has a dividend yield of 0.97%.
EPS growth for the last five years have been -7.60%, more recently this last year it has grown by 90.50%. The next year growth is going to be about 14.60% and more long-term 10.70% after five years. EPS growth quarter over quarter is 19.60%. Sales growth for the past five years have been -5.80% and sales growth quarter over quarter is 3.00%.
For performance, Agilent Technologies, Inc. the past week has seen a gain of -0.63%. For the last month performance for Agilent Technologies, Inc. is -0.40%. While the last quarter is 3.55% and half year, 27.39%. Finally for the year, performance is 30.60%.
The 52-week high for Agilent Technologies, Inc., is at -2.69%, and for the 52-week low it comes to a value of 44.06%. The 20-day simple moving average is 1.96% and 13.57% for the 200-day simple moving average.
Volatility for the week is at 1.53%, and for the month it is 1.37%. Agilent Technologies, Inc., has a target price of 50.23.
In terms of debt, long term debt/equity is 0.38, and for total debt/equity Agilent Technologies, Inc. has 0.43. The gross margin is 52.00%, while operating margin is 14.30%, the profit margin is 11.70%. The current ratio is 3.1 and the quick ratio is 2.6.
Insider ownership is at 0.20%, with instituitional ownership at 87.30%. Agilent Technologies, Inc. has a payout ratio of 30.30%. With the total shares outstanding coming to 325.11. The shares float is 322.28, with the float short at 0.88%, with short ratio coming to 1.39.
In terms of returns, the return on assets see Agilent Technologies, Inc., get 6.40%, with its returns on investment at 8.20%. Return on equity is 11.50%. So will the investors see the target price of 50.23, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.